— Know what they know.
Not Investment Advice

EVMN NYSE

Evommune, Inc.
1W: +3.4% 1M: -13.3% 3M: -17.0% YTD: +35.8%
$22.87
-0.68 (-2.89%)
 
Weekly Expected Move ±6.5%
$20 $21 $23 $24 $26
NYSE · Healthcare · Biotechnology · Alpha Radar Neutral · Power 40 · $323.9M mcap · 14M float · 2.48% daily turnover · Short 81% of daily vol

Balance Sheet Trends

Total Assets
$225M +195.8% ▲
Total Liabilities
$19M -91.2% ▼
Shareholders Equity
$206M +242.5% ▲
Cash & Investments
$149M +107.1% ▲
Total Debt
$2M -98.9% ▼
Net Debt
-$42M -123.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2023FY2024FY2025
— Assets —
Cash$29M$16M$44M
Short-Term Investments$50M$56M$105M
Cash & ST Investments$79M$72M$149M
Net Receivables$0$0$0
Inventory$0$0$0
Other Current Assets$948K$2M$4M
Total Current Assets$80M$74M$153M
Property, Plant & Equip.$2M$2M$2M
Goodwill & Intangibles$0$0$0
Long-Term Investments$208K$208K$69M
Other Non-Current Assets$44K$61K$101K
Total Non-Current Assets$2M$2M$71M
Total Assets$82M$76M$225M
— Liabilities —
Accounts Payable$2M$8M$8M
Short-Term Debt$769K$1M$589K
Deferred Revenue$0$3M$0
Other Current Liabilities$2M$12M$5M
Total Current Liabilities$7M$28M$18M
Long-Term Debt$149M$192M$0
Other Non-Current Liab.$245K$16K$0
Total Non-Current Liabilities$153M$192M$1M
Total Liabilities$160M$220M$19M
— Equity —
Common Stock$1K$1K$3K
Retained Earnings-$84M-$152M-$221M
Accumulated OCI$0$0$0
Total Stockholders Equity-$78M-$144M$206M
Total Liabilities & Equity$82M$76M$225M
— Key Metrics —
Total Debt$151M$193M$2M
Net Debt$122M$177M-$42M
Total Investments$50M$56M$174M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms